s-atenolol

This page covers all s-atenolol drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Adenosine receptor A3, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor.

Targets

Adenosine receptor A3, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor

Phase 2 pipeline (1)

• (-)-Atenolol · Cardiovascular
  ESATENOLOL works by binding to the adenosine receptor A3, which can affect various physiological processes.

Patent intelligence

• s atenolol patent landscape — aggregated cliff calendar, attackable patents, originator estates